Heart Failure Reviews

, Volume 19, Issue 5, pp 637–644 | Cite as

Critical appraisal of the obesity paradox in cardiovascular disease: How to manage patients with overweight in heart failure?

  • Wolfram Doehner


Overweight has been shown in multiple studies to carry a survival benefit in heart failure (HF) patients. This finding is, of course, counterintuitive to the well-established role of obesity as a modifiable risk factor for incident cardiovascular disease. The debate on the relevance of this obesity paradox is on-going, and clinical, methodological and teleological aspects are discussed. Particularly, younger age and a seemingly favourable clinical status of obese patients are repeatedly discussed together with the lack of prospective data to question the validity of the observed survival advantage in obese HF patients. Recent risk score calculators, however, have included body weight as an inverse risk factor, i.e. higher body mass index is predicting better outcome. Emerging prospective interventional trials support the concept that in patients with established disease, intentional weight reduction may not necessarily translate into improved outcome. The clinically most relevant consequence from the emerging data is, of course, the practical recommendation on body weight management that we may give our (overweight) patients. While the terminology as a paradox is critically discussed, a more differentiated concept for weight management should be emphasized that distinguishes between healthy subjects and those with an established cardiovascular disease such as heart failure.


Heart failure Overweight Obesity Mortality Secondary disease prevention 


Conflict of interest



  1. 1.
    Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M et al (2012) A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:222–260CrossRefGoogle Scholar
  2. 2.
    Davos CH, Doehner W, Rauchhaus M, Cicoira M, Francis D, Anker SD (2000) Obesity and survival in chronic heart failure. Circulation 102(Suppl I):I4202Google Scholar
  3. 3.
    Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH (2001) The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 38:789–795PubMedCrossRefGoogle Scholar
  4. 4.
    Guglin M, Baxi K, Schabath M (2013) Anatomy of the obesity paradox in heart failure. Heart Fail Rev. doi: 10.1007/s10741-013-9406-7 Google Scholar
  5. 5.
    Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M et al (2012) European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 33:1635–1701PubMedCrossRefGoogle Scholar
  6. 6.
    Lissin LW, Gauri AJ, Froelicher VF, Ghayoumi A, Myers J, Giacommini J (2002) The prognostic value of body mass index and standard exercise testing in male veterans with congestive heart failure. J Card Fail 8:206–215PubMedCrossRefGoogle Scholar
  7. 7.
    Davos CH, Doehner W, Rauchhaus M, Cicoira M, Francis DP, Coats AJ, Clark AL, Anker SD (2003) Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail 9:29–35PubMedCrossRefGoogle Scholar
  8. 8.
    Lavie CJ, Osman AF, Milani RV, Mehra MR (2003) Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol 91:891–894PubMedCrossRefGoogle Scholar
  9. 9.
    Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC (2004) Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 43:1439–1444PubMedCrossRefGoogle Scholar
  10. 10.
    Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, Kosiborod M, Portnay EL, Sokol SI, Bader F, Krumholz HM (2005) The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 165:55–61PubMedCrossRefGoogle Scholar
  11. 11.
    Gustafsson F, Kragelund CB, Torp-Pedersen C, Seibaek M, Burchardt H, Akkan D, Thune JJ, Kober L (2005) Effect of obesity and being overweight on long-term mortality in congestive heart failure: influence of left ventricular systolic function. Eur Heart J 26:58–64PubMedCrossRefGoogle Scholar
  12. 12.
    Bozkurt B, Deswal A (2005) Obesity as a prognostic factor in chronic symptomatic heart failure. Am Heart J 150:1233–1239PubMedCrossRefGoogle Scholar
  13. 13.
    Butler J, Howser R, Portner PM, Pierson RN 3rd (2005) Body mass index and outcomes after left ventricular assist device placement. Ann Thorac Surg 79:66–73PubMedCrossRefGoogle Scholar
  14. 14.
    Fonarow GC, Srikanthan P, Costanzo MR, Cintron GB, Lopatin M (2007) An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J 153:74–81PubMedCrossRefGoogle Scholar
  15. 15.
    Kenchaiah S, Pocock SJ, Wang D, Finn PV, Zornoff LA, Skali H, Pfeffer MA, Yusuf S, Swedberg K, Michelson EL, Granger CB, McMurray JJ, Solomon SD (2007) Body mass index and prognosis in patients with chronic heart failure: insights from the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program. Circulation 116:627–636PubMedCrossRefGoogle Scholar
  16. 16.
    Cicoira M, Maggioni AP, Latini R, Barlera S, Carretta E, Janosi A, Soler Soler J, Anand I, Cohn JN (2007) Body mass index, prognosis and mode of death in chronic heart failure: results from the Valsartan heart failure trial. Eur J Heart Fail 9:397–402PubMedCrossRefGoogle Scholar
  17. 17.
    Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA (2008) Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 156:13–22PubMedCrossRefGoogle Scholar
  18. 18.
    Chase P, Arena R, Myers J, Abella J, Peberdy MA, Guazzi M, Bensimhon D (2008) Relation of the prognostic value of ventilatory efficiency to body mass index in patients with heart failure. Am J Cardiol 101:348–352PubMedCrossRefGoogle Scholar
  19. 19.
    Abdulla J, Køber L, Abildstrøm SZ, Christensen E, James WP, Torp-Pedersen C (2008) Impact of obesity as a mortality predictor in high-risk patients with myocardial infarction or chronic heart failure: a pooled analysis of five registries. Eur Heart J 29:594–601PubMedCrossRefGoogle Scholar
  20. 20.
    Pocock SJ, McMurray JJ, Dobson J, Yusuf S, Granger CB, Michelson EL, Ostergren J, Pfeffer MA, Solomon SD, Anker SD, Swedberg KB (2008) Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. Eur Heart J 29:2641–2650PubMedCrossRefGoogle Scholar
  21. 21.
    Arena R, Myers J, Abella J, Pinkstaff S, Brubaker P, Moore B, Kitzman D, Peberdy MA, Bensimhon D, Chase P, Forman D, West E, Guazzi M (2009) Influence of etiology of heart failure on the obesity paradox. Am J Cardiol 104:1116–1121PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    Kapoor JR, Heidenreich PA (2010) Obesity and survival in patients with heart failure and preserved systolic function: a U-shaped relationship. Am Heart J 159:75–80PubMedCrossRefGoogle Scholar
  23. 23.
    Choy B, Hansen E, Moss AJ, McNitt S, Zareba W, Goldenberg I (2010) Relation of body mass index to sudden cardiac death and the benefit of implantable cardioverter-defibrillator in patients with left ventricular dysfunction after healing of myocardial infarction. Am J Cardiol 105:581–586PubMedCrossRefGoogle Scholar
  24. 24.
    Doesch C, Suselbeck T, Leweling H, Fluechter S, Haghi D, Schoenberg SO, Borggrefe M, Papavassiliu T (2010) Bioimpedance analysis parameters and epicardial adipose tissue assessed by cardiac magnetic resonance imaging in patients with heart failure. Obesity (Silver Spring) 18:2326–2332CrossRefGoogle Scholar
  25. 25.
    Clark AL, Fonarow GC, Horwich TB (2011) Waist circumference, body mass index, and survival in systolic heart failure: the obesity paradox revisited. J Card Fail 17:374–380PubMedCrossRefGoogle Scholar
  26. 26.
    Futter JE, Cleland JG, Clark AL (2011) Body mass indices and outcome in patients with chronic heart failure. Eur J Heart Fail 13:207–213PubMedCrossRefGoogle Scholar
  27. 27.
    Gastelurrutia P, Pascual-Figal D, Vazquez R, Cygankiewicz I, Shamagian LG, Puig T, Ferrero A, Cinca J, de Luna AB, Bayes-Genis A (2011) Obesity paradox and risk of sudden death in heart failure results from the MUerte Subita en Insuficiencia cardiaca (MUSIC) study. Am Heart J 161:158–164PubMedCrossRefGoogle Scholar
  28. 28.
    Casas-Vara A, Santolaria F, Fernandez-Bereciartua A, Gonzalez-Reimers E, Garcia-Ochoa A, Martinez-Riera A (2012) The obesity paradox in elderly patients with heart failure: analysis of nutritional status. Nutrition 28:616–622PubMedCrossRefGoogle Scholar
  29. 29.
    Schwartzenberg S, Benderly M, Malnick S, George J, Goland S (2012) The, “obesity paradox”: does it persist among Israeli patients with decompensated heart failure? A subanalysis of the heart failure survey in Israel (HFSIS). J Card Fail 18:62–67PubMedCrossRefGoogle Scholar
  30. 30.
    Clark AL, Chyu J, Horwich TB (2012) The obesity paradox in men versus women with systolic heart failure. Am J Cardiol 110:77–82PubMedCentralPubMedCrossRefGoogle Scholar
  31. 31.
    Zamora E, Lupon J, de Antonio M, Urrutia A, Coll R, Diez C, Altimir S, Bayes-Genis A (2013) The obesity paradox in heart failure: is etiology a key factor? Int J Cardiol 166:601–605PubMedCrossRefGoogle Scholar
  32. 32.
    Nagarajan V, Cauthen CA, Starling RC, Tang WH (2013) Prognosis of morbid obesity patients with advanced heart failure. Congest Heart Fail 19:160–164PubMedCrossRefGoogle Scholar
  33. 33.
    Zuchinali P, Souza GC, Alves FD, d’Almeida KS, Goldraich LA, Clausell NO, Rohde LE (2013) Triceps skinfold as a prognostic predictor in outpatient heart failure. Arq Bras Cardiol 101:434–441PubMedCentralPubMedGoogle Scholar
  34. 34.
    Padwal R, McAlister FA, McMurray JJ, Cowie MR, Rich M, Pocock S, Swedberg K, Maggioni A, Gamble G, Ariti C, Earle N, Whalley G, Poppe KK, Doughty RN, Bayes-Genis A (2013) The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data. Int J Obes (Lond). doi: 10.1038/ijo.2013.203 Google Scholar
  35. 35.
    Puig T, Ferrero-Gregori A, Roig E, Vazquez R, Gonzalez-Juanatey JR, Pascual-Figal D, Delgado J, Alonso-Pulpon L, Borras X, Mendez A, Cinca J (2014) Prognostic value of body mass index and waist circumference in patients with chronic heart failure (Spanish REDINSCOR Registry). Rev Esp Cardiol 67:101–106CrossRefGoogle Scholar
  36. 36.
    Shah R, Gayat E, Januzzi JL, Sato N, Cohen-Solal A, Disomma S, Fairman E, Harjola VP, Ishihara S, Lassus J, Maggioni A, Metra M, Mueller C, Mueller T, Parenica J, Pascual-Figal D, Peacock F, Spinar J, van Kimmenade R, Mebazaa A, For the GREAT Network (2013) Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox. J Am Coll Cardiol. doi: 10.1016/j.jacc.2013.09.072 Google Scholar
  37. 37.
    Wannamethee SG, Shaper AG, Whincup PH, Lennon L, Papacosta O, Sattar N (2014) The obesity paradox in men with coronary heart disease and heart failure: the role of muscle mass and leptin. Int J Cardiol 171:49–55PubMedCentralPubMedCrossRefGoogle Scholar
  38. 38.
    Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, Harrington D, Kox WJ, Poole-Wilson PA, Coats AJ (1997) Wasting as independent risk factor for mortality in chronic heart failure. Lancet 349:1050–1053PubMedCrossRefGoogle Scholar
  39. 39.
    Anker SD, Negassa A, Coats AJ, Afzal R, Poole-Wilson PA, Cohn JN, Yusuf S (2003) Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 361:1077–1083PubMedCrossRefGoogle Scholar
  40. 40.
    Coutinho T, Goel K, Corrêa de Sá D, Carter RE, Hodge DO, Kragelund C, Kanaya AM, Zeller M, Park JS, Kober L, Torp-Pedersen C, Cottin Y, Lorgis L, Lee SH, Kim YJ, Thomas R, Roger VL, Somers VK, Lopez-Jimenez F (2013) Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: role of “normal weight central obesity”. J Am Coll Cardiol 61:553–560PubMedCrossRefGoogle Scholar
  41. 41.
    Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285:2486–2497CrossRefGoogle Scholar
  42. 42.
    Wildman RP, Muntner P, Reynolds K et al (2008) The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch Intern Med 168:1617–1624PubMedCrossRefGoogle Scholar
  43. 43.
    Karelis AD, Rabasa-Lhoret R (2008) Inclusion of C-reactive protein in the identification of metabolically healthy but obese (MHO) individuals. Diabetes Metab 34:183–184PubMedCrossRefGoogle Scholar
  44. 44.
    Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, Rittig K, Balletshofer B, Machicao F, Fritsche A, Häring HU (2008) Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 168:1609–1616PubMedCrossRefGoogle Scholar
  45. 45.
    Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM, D’Agostino RB (2006) Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 91:2906–2912PubMedCrossRefGoogle Scholar
  46. 46.
    Doehner W, Pfeiffer AF (2014) Is all obesity the same? The skills to distinguish. Diabetes Care 37:e1. doi: 10.2337/dc132748
  47. 47.
    Look AHEAD Research Group (2013) Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 369:145–154CrossRefGoogle Scholar
  48. 48.
    Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, Skene AM, Tan MH, Lefèbvre PJ, Murray GD, Standl E, Wilcox RG, Wilhelmsen L, Betteridge J, Birkeland K, Golay A, Heine RJ, Korányi L, Laakso M, Mokán M, Norkus A, Pirags V, Podar T, Scheen A, Scherbaum W, Schernthaner G, Schmitz O, Skrha J, Smith U, Taton J, PROactive investigators (2005) Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone clinical trial in macrovascular events): a randomised controlled trial. Lancet 366:1279–1289PubMedCrossRefGoogle Scholar
  49. 49.
    Doehner W, Erdmann E, Cairns R, Clark AL, Dormandy JA, Ferrannini E, Anker SD (2012) Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population. Int J Cardiol 162:20–26PubMedCrossRefGoogle Scholar
  50. 50.
    Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, Anand I, Maggioni A, Burton P, Sullivan MD, Pitt B, Poole-Wilson PA, Mann DL, Packer M (2006) The Seattle heart failure model: prediction of survival in heart failure. Circulation 113:1424–1433PubMedCrossRefGoogle Scholar
  51. 51.
    Pocock SJ, Ariti CA, McMurray JJ, Maggioni A, Køber L, Squire IB, Swedberg K, Dobson J, Poppe KK, Whalley GA, Doughty RN (2013) Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. Meta-analysis global group in chronic heart failure. Eur Heart J 34:1404–1413PubMedCrossRefGoogle Scholar
  52. 52.
    Schulze PC, Gielen S, Adams V, Linke A, Möbius-Winkler S, Erbs S, Kratzsch J, Hambrecht R, Schuler G (2003) Muscular levels of proinflammatory cytokines correlate with a reduced expression of insulin like growth factor-I in chronic heart failure. Basic Res Cardiol 98:267–274PubMedGoogle Scholar
  53. 53.
    Doehner W, Rauchhaus M, Ponikowski P, Godsland IF, von Haehling S, Okonko DO, Leyva F, Proudler AJ, Coats AJ, Anker SD (2005) Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure. J Am Coll Cardiol 46:1019–1026PubMedCrossRefGoogle Scholar
  54. 54.
    Anker SD, Volterrani M, Pflaum CD, Strasburger CJ, Osterziel KJ, Doehner W, Ranke MB, Poole-Wilson PA, Giustina A, Dietz R, Coats AJ (2001) Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone. J Am Coll Cardiol 38:443–452PubMedCrossRefGoogle Scholar
  55. 55.
    Sengenes C, Bouloumie A, Hauner H, Berlan M, Busse R, Lafontan M, Galitzky J (2003) Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes. J Biol Chem 278:48617–48626PubMedCrossRefGoogle Scholar
  56. 56.
    Szabó T, Postrach E, Mähler A, Kung T, Turhan G, von Haehling S, Anker SD, Boschmann M, Doehner W (2013) Increased catabolic activity in adipose tissue of patients with chronic heart failure. Eur J Heart Fail 15:1131–1137PubMedCrossRefGoogle Scholar
  57. 57.
    Anker SD, Chua TP, Ponikowski P, Harrington D, Swan JW, Kox WJ, Poole-Wilson PA, Coats AJ (1997) Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 96:526–534PubMedCrossRefGoogle Scholar
  58. 58.
    Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL (2013) 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62:e147–e239PubMedCrossRefGoogle Scholar
  59. 59.
    ESC Committee for Practice Guidelines (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14:803–869CrossRefGoogle Scholar
  60. 60.
    Uretsky S, Messerli FH, Bangalore S, Champion A, Cooper-Dehoff RM, Zhou Q, Pepine CJ (2007) Obesity paradox in patients with hypertension and coronary artery disease. Am J Med 120:863–870PubMedCrossRefGoogle Scholar
  61. 61.
    Kadakia MB, Fox CS, Scirica BM, Murphy SA, Bonaca MP, Morrow DA (2011) Central obesity and cardiovascular outcomes in patients with acute coronary syndrome: observations from the MERLIN-TIMI 36 trial. Heart 97:1782–1787PubMedCrossRefGoogle Scholar
  62. 62.
    Diercks DB, Roe MT, Mulgund J, Pollack CV Jr, Kirk JD, Gibler WB, Ohman EM, Smith SC Jr, Boden WE, Peterson ED (2006) The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the Can Rapid risk stratification of unstable angina patients suppress ADverse outcomes with early implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Initiative. Am Heart J 152:140–148PubMedCrossRefGoogle Scholar
  63. 63.
    Buettner HJ, Mueller C, Gick M, Ferenc M, Allgeier J, Comberg T, Werner KD, Schindler C, Neumann FJ (2007) The impact of obesity on mortality in UA/non-ST-segment elevation myocardial infarction. Eur Heart J 28:1694–1701PubMedCrossRefGoogle Scholar
  64. 64.
    Kennedy LM, Dickstein K, Anker SD, Kristianson K, Willenheimer R, OPTIMAAL Study Group (2005) The prognostic importance of body mass index after complicated myocardial infarction. J Am Coll Cardiol 45:156–158PubMedCrossRefGoogle Scholar
  65. 65.
    Kennedy LM, Dickstein K, Anker SD, James M, Cook TJ, Kristianson K, Willenheimer R (2006) Weight-change as a prognostic marker in 12 550 patients following acute myocardial infarction or with stable coronary artery disease. Eur Heart J 27:2755–2762PubMedCrossRefGoogle Scholar
  66. 66.
    Doehner W, Schenkel J, Anker SD, Springer J, Audebert HJ (2013) Overweight and obesity are associated with improved survival, functional outcome, and stroke recurrence after acute stroke or transient ischaemic attack: observations from the TEMPiS trial. Eur Heart J 34:268–277PubMedCrossRefGoogle Scholar
  67. 67.
    Sierra-Johnson J, Wright SR, Lopez-Jimenez F, Allison TG (2005) Relation of body mass index to fatal and nonfatal cardiovascular events after cardiac rehabilitation. Am J Cardiol 96:211–214PubMedCrossRefGoogle Scholar
  68. 68.
    Badheka AO, Rathod A, Kizilbash MA, Garg N, Mohamad T, Afonso L, Jacob S (2010) Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox. Am J Med 123:646–651PubMedCrossRefGoogle Scholar
  69. 69.
    Gruberg L, Weissman NJ, Waksman R, Fuchs S, Deible R, Pinnow EE, Ahmed LM, Kent KM, Pichard AD, Suddath WO, Satler LF, Lindsay J Jr (2002) The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol 39:578–584PubMedCrossRefGoogle Scholar
  70. 70.
    Kaneko H, Yajima J, Oikawa Y, Tanaka S, Fukamachi D, Suzuki S, Sagara K, Otsuka T, Matsuno S, Funada R, Kano H, Uejima T, Koike A, Nagashima K, Kirigaya H, Sawada H, Aizawa T, Yamashita T (2013) Obesity paradox in Japanese patients after percutaneous coronary intervention: an observation cohort study. J Cardiol 62:18–24PubMedCrossRefGoogle Scholar
  71. 71.
    Nikolsky E, Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Negoita M, Lansky AJ, Mehran R (2006) Impact of body mass index on outcomes after primary angioplasty in acute myocardial infarction. Am Heart J 151:168–175PubMedCrossRefGoogle Scholar
  72. 72.
    Ndrepepa G, Keta D, Byrne RA, Schulz S, Mehilli J, Seyfarth M, Schömig A, Kastrati A (2010) Impact of body mass index on clinical outcome in patients with acute coronary syndromes treated with percutaneous coronary intervention. Heart Vessel 25:27–34CrossRefGoogle Scholar
  73. 73.
    van der Boon RM, Chieffo A, Dumonteil N, Tchetche D, Van Mieghem NM, Buchanan GL, Vahdat O, Marcheix B, Serruys PW, Fajadet J, Colombo A, Carrié D, van Domburg RT, PP de Jaegere PP, RAGMATIC-Plus Researchers (2013) Effect of body mass index on short- and long-term outcomes after transcatheter aortic valve implantation. Am J Cardiol 111:231–236PubMedCrossRefGoogle Scholar
  74. 74.
    Jackson RS, Black JH 3rd, Lum YW, Schneider EB, Freischlag JA, Perler BA, Abularrage CJ (2012) Class I obesity is paradoxically associated with decreased risk of postoperative stroke after carotid endarterectomy. J Vasc Surg 5:1306–1312CrossRefGoogle Scholar
  75. 75.
    Potapov EV, Loebe M, Anker S, Stein J, Bondy S, Nasseri BA, Sodian R, Hausmann H, Hetzer R (2003) Impact of body mass index on outcome in patients after coronary artery bypass grafting with and without valve surgery. Eur Heart J 24:1933–1941PubMedCrossRefGoogle Scholar
  76. 76.
    Le-Bert G, Santana O, Pineda AM, Zamora C, Lamas GA, Lamelas J (2011) The obesity paradox in elderly obese patients undergoing coronary artery bypass surgery. Interact CardioVasc Thorac Surg 13:124–127PubMedCrossRefGoogle Scholar
  77. 77.
    Stamou SC, Nussbaum M, Stiegel RM, Reames MK, Skipper ER, Robicsek F, Lobdell KW (2011) Effect of body mass index on outcomes after cardiac surgery: is there an obesity paradox? Ann Thorac Surg 91:42–47PubMedCrossRefGoogle Scholar
  78. 78.
    Sung SH, Wu TC, Huang CH, Lin SJ, Chen JW (2011) Prognostic impact of body mass index in patients undergoing coronary artery bypass surgery. Heart 97:648–654PubMedCrossRefGoogle Scholar
  79. 79.
    Florath I, Albert AA, Rosendahl UP, Hassanein WM, Bauer S, Ennker IC, Ennker JC (2006) Body mass index: a risk factor for 30-day or six-month mortality in patients undergoing aortic valve replacement? J Heart Valve Dis 15:336–344PubMedGoogle Scholar
  80. 80.
    van Kuijk JP, Flu WJ, Galal W, Chonchol M, Goei D, Verhagen HJ, Bax JJ, Poldermans D (2011) The influence of polyvascular disease on the obesity paradox in vascular surgery patients. J Vasc Surg 53:399–406PubMedCrossRefGoogle Scholar
  81. 81.
    Davenport DL, Xenos ES, Hosokawa P, Radford J, Henderson WG, Endean ED (2009) The influence of body mass index obesity status on vascular surgery 30-day morbidity and mortality. J Vasc Surg 49:140–147PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Centre for Stroke Research Berlin and Department of CardiologyCharité-Universitätsmedizin Berlin, Campus Virchow-KlinikumBerlinGermany

Personalised recommendations